PDSB Archived Articles
PDS Biotechnology (PDSB): Revolutionizing Cancer Immunotherapy with Versamune® Platform
Published on March 14, 2025
PDS Biotechnology Corporation (PDSB): Navigating the Evolving Immunotherapy Landscape with Innovative Investigational Therapies
Published on November 26, 2024
PDS Biotech Corporation (NASDAQ:PDSB): Transformative Oncology Platform Poised for Pivotal Advancement
Published on September 24, 2024